Nagesh H. Jayaram, MD

dr jayaram

Dr. Nagesh H. Jayaram

Jacksonville

Dr. Jayaram joined SMOC in August 2011. He is board certified in oncology and hematology. Dr. Jayaram completed his internal medicine residency and hematology / oncology fellowship at Indiana University School of Medicine in Indianapolis, Indiana. He received his medical degree from St. George’s University School of Medicine in St. George’s, Grenada. He holds a Bachelor of Pharmacy degree from Butler University in Indianapolis, Indiana. SMOC is excited to have Dr. Jayaram as a full-time physician at our Jacksonville office.

2001-2005St. George’s University School of Medicine, Grenada, West Indies. MD received May 2005
1995-1998Butler University College of Pharmacy
Indianapolis, IN
Bachelor of Science of Pharmacy
1993-1995Indiana University
Bloomington, IN
Microbiology Major
December 2012Board Certified in Hematology
December 2011Board Certified in Oncology
June 2011Board Eligible Hematology and Oncology
June 2010 – June 2011Indiana University School of Medicine
Indianapolis, INHematology/Oncology Chief Fellow
2008 – PresentIndiana University School of Medicine
Indianapolis, INHematology/Oncology Fellowship
October 2008Board Certification Internal Medicine
March 2008Wishard Hospital
Indiana University School of Medicine
Indianapolis, INInterim Chief Resident
2006-2008Indiana University School of Medicine
Indianapolis, INInternal Medicine Residency
2005-2006Indiana University School of Medicine
Indianapolis, INInternal Medicine Internship
Residency/Fellowship

Research Assistant with Professor Asok C.Antony and Prof. H.N. Jayaram, Indiana University School of Medicine, Department of Hematology and Oncology, Indianapolis, IN. Work involved constructing folate-tethered and non-targeted liposomes containing Tiazofurin. liposomes then tested in HD29 and Caco-2 colon cancer cell lines expressing folate receptors. Cytotoxicity studies currently ongoing.

Research with Professor Nasser Hanna, Indiana University School of Medicine, Department of Hematology and Oncology, Indianapolis, IN., involving treatment of extensive Small Cell Lung Cancer. This involved development of a protocol for a randomized, phase II study with Cisplatin plus Etoposide with/without concurrent ZD6474, a novel tyrosine kinase and angiogenesis inhibitor, in patients with previously untreated extensive stage SCLC. Study has funding and protocol is currently pending IRB approval.

Undergraduate

Indiana University School of Medicine, Indianapolis, IN
Research Assistant with Prof. Arun Srivastava, Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN. Helped in research involving adeno-associated viruses in order to increase the efficiency of gene transfer.


Research Assistant with Prof. H. N. Jayaram, Department of
Biochemistry and Molecular Biology. Research involved elucidation of the mechanism of action of a new anticancer compound, Benzamide Riboside. This work culminated in Co-authorship in a publication.

 

Research Assistant with Prof. George Weber, Director, Experimental Oncology Laboratory, Indiana University School of Medicine, Indianapolis, IN. Work involved the determination of effect of Tiazofurin, a recent anticancer agent, on IMP dehydrogenase in hepatoma cells.

2010 Poster presentation, ASCO 2010, “The impact of PET imaging on outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with chemoradiation: A subset analysis of HOG LUN 01-24/USO-023.” Winner ASCO 2010 Merit Award for above poster presentation.
March 2008 Winner Best Chairman’s Rounds presentation titled “Erythrocytosis and Polycythemia,” given March 2008.
2005 Winner State ACP Abstract competition, 4th place, 2005 for abstract titled “Persistent hiccups as the initial presentation of metastatic colorectal adenocarcinoma” and was given opportunity to present poster at 2005 Indiana Chapter ACP meeting.
Member of Iota Epsilon Alpha (IEA) Honor Medical Society
December 2001 – December 2005 Dean’s List, St. George’s University School of Medicine
Hiremagalur N. Jayaram, Kamran Gharehbaghi, Nagesh H. Jayaram, Jason Rieser, Karsten Krohn and Kenneth D. Paull. (1992). Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells. Biochemical and Biophysical Research Communication 186, 1600-1606.Loehrer, Patrick J., Jayaram, Nagesh, Dash, Atreya, Buyyounowski, Mark K., Sharecky, Douglass. “Testicular Cancer.” Cancer Management: A Multidisciplinary Approach. CMPMedica, 2009. 425-448.Kusumanchi P, Zhang Y, Jayaram N, Antony Asok, Jayaram H. Pro-Drug Targeted Gene Therapy for Colorectal Cancer. Brit J Cancer 2010 (in press).Jayaram N, Neubauer M, Johnson CS, Breen T, Williams C, Hanna N. The impact of PET imaging on outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with chemoradiation: A subset analysis of HOG LUN 01-24/USO-023. J Clin Oncol 28:7s, 2010 (suppl; abstr 7065), submitted to J Thor Oncol for brief report publication June 2011.
American Society of Clinical Oncologists (ASCO)- American Society of Hematology (ASH)- American College of Physicians (ACP)
Married to Smitha Jayaram, together they have a daughter Aneesha and son Tejas.
Tennis
Mountain Biking
Scuba Diving
Reading

Send Dr. Jayaram a Message

*All Fields Required